These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9247888)
1. Total abrogation of facial seborrhoeic dermatitis with extremely low-frequency (1-1.1 Hz) 'imprinted' water is not allergen or hapten dependent: a new visible model for homoeopathy. Sudan BJ Med Hypotheses; 1997 Jun; 48(6):477-9. PubMed ID: 9247888 [TBL] [Abstract][Full Text] [Related]
2. Abrogation of facial seborrhoeic dermatitis with homoeopathic high dilutions of tobacco: a new visible model for Benveniste's theory of 'Memory of water'. Sudan BJ Med Hypotheses; 1993 Nov; 41(5):440-4. PubMed ID: 8145656 [TBL] [Abstract][Full Text] [Related]
3. Nicotine skin patch treatment and adverse reactions: skin irritation, skin sensitization, and nicotine as a hapten. Sudan BJ J Clin Psychopharmacol; 1995 Apr; 15(2):145-6. PubMed ID: 7632289 [No Abstract] [Full Text] [Related]
4. Ketoconazole, leukotrienes, Paf-acether and nicotine as a hapten: the possible aetiology of seborrhoeic dermatitis. Sudan BJ Med Hypotheses; 1987 May; 23(1):33-8. PubMed ID: 2886895 [TBL] [Abstract][Full Text] [Related]
5. Nicotine as a hapten in seborrhoeic dermatitis. Sudan BJ; Brouillard C; Sterboul J; Sainte-Laudy J Contact Dermatitis; 1984 Sep; 11(3):196-7. PubMed ID: 6238797 [No Abstract] [Full Text] [Related]
6. [Tobacco sensitization; tobacco as allergen; nicotine as hapten. Diagnosis by the basophil degranulation test (author's transl)]. Sudan BJ; Sterboul J Nouv Presse Med; 1979 Nov; 8(43):3563. PubMed ID: 545289 [No Abstract] [Full Text] [Related]
14. Seborrhoeic dermatitis of the face induced by PUVA treatment. Tegner E Acta Derm Venereol; 1983; 63(4):335-9. PubMed ID: 6195866 [TBL] [Abstract][Full Text] [Related]
15. The treatment of seborrhoeic dermatitis. BOLAM RM Practitioner; 1946 May; 156():353-7. PubMed ID: 21028032 [No Abstract] [Full Text] [Related]
16. Topical antifungals for seborrhoeic dermatitis. Okokon EO; Verbeek JH; Ruotsalainen JH; Ojo OA; Bakhoya VN Cochrane Database Syst Rev; 2015 May; (5):CD008138. PubMed ID: 25933684 [TBL] [Abstract][Full Text] [Related]
17. [Seborrhoeic dermatitis: clinical manifestations and management]. Menzinger S; Laffitte E Rev Med Suisse; 2011 Apr; 7(289):752-4, 756-8. PubMed ID: 21568097 [TBL] [Abstract][Full Text] [Related]
18. Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies. Bergbrant IM Acta Derm Venereol Suppl (Stockh); 1991; 167():1-36. PubMed ID: 1839943 [TBL] [Abstract][Full Text] [Related]